阻塞性睡眠呼吸暂停患者的围术期管理:叙述性综述
本综述总结OSA围术期管理要点:术前筛查识别高危患者,专家建议无严重症状或额外健康风险者可继续手术但需加强术后监护;围术期应预见困难气道,麻醉镇静药加重上气道塌陷和抑制中枢呼吸,神经肌肉阻滞增加术后呼吸损害风险,阿片类易致呼吸抑制;区域麻醉和多模式镇痛获强烈支持;亟需筛查监测流程和可靠风险预测工具。
要点
- 术前筛查识别OSA高危患者,无严重症状或额外风险可手术但需加强术后监护。
- OSA患者围术期应预见困难气道并准备处理气道并发症。
- 区域麻醉和多模式镇痛可降低OSA患者围术期并发症风险。
核心结论
- 区域麻醉和多模式镇痛获文献强烈支持,可降低OSA患者围术期并发症风险。
- 亟需筛查监测流程和可靠风险预测工具,识别真正需要延长术后监护的OSA患者。
研究设计与样本
- 叙述性综述,总结OSA围术期管理的主要方面和考虑因素。
主要发现
- OSA围术期风险关键决定因素包括上气道解剖改变致塌陷性增加、上气道扩张肌对梗阻反应能力下降、低氧和高碳酸血症觉醒阈值差异及通气控制不稳定。
- 麻醉和镇静药物加重上气道塌陷并抑制中枢呼吸活动,使用神经肌肉阻滞进一步增加术后呼吸损害风险。
- 阿片类镇痛在OSA中复杂,患者易发生阿片诱导呼吸抑制,且间歇低氧和反复睡眠碎片化增加阿片镇痛效力和疼痛感知。
- 许多机构已实施术前OSA筛查以识别风险增加的患者。
关键数值与推荐
- 专家推荐:无严重症状或额外 compounding 健康风险时,患者可继续手术,但需提高警惕并调整术后护理。
- 文献强烈支持区域麻醉(直接阻断手术创伤部位神经通路)和多模式镇痛(利用相加和协同镇痛效应)作为可能降低围术期并发症风险的干预。
临床怎么用
- 术前进行OSA筛查识别高危患者,围术期预见困难气道并准备处理气道并发症。
- 优先考虑区域麻醉和多模式镇痛,减少阿片类用药以降低呼吸抑制风险。
- 对OSA患者加强术后监护,医疗机构应分配资源包括术后增强监测。
局限性
- OSA患病率上升、疾病严重程度异质性大,且缺乏昂贵围术期措施有效性的证据,阻碍循证管理策略实施。
- 缺乏可靠风险预测工具和筛查监测算法,难以识别真正需要延长术后监护的OSA患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The prevalence of obstructive sleep apnea (OSA) has reached 1 billion people worldwide, implying significant risk for the perioperative setting as patients are vulnerable to cardiopulmonary complications, critical care requirement, and unexpected death. This review summarizes main aspects and considerations for the perioperative management of OSA, a condition of public health concern. Critical determinants of perioperative risk include OSA-related changes in upper airway anatomy with augmented collapsibility, diminished capability of upper airway dilator muscles to respond to airway obstruction, disparities in hypoxemia and hypercarbia arousal thresholds, and instability of ventilatory control. Preoperative OSA screening to identify patients at increased risk has therefore been implemented in many institutions. Experts recommend that in the absence of severe symptoms or additional compounding health risks, patients may nevertheless proceed to surgery, while heightened awareness and the adjustment of postoperative care is required. Perioperative caregivers should anticipate difficult airway management in OSA and be prepared for airway complications. Anesthetic and sedative drug agents worsen upper airway collapsibility and depress central respiratory activity, while the risk for postoperative respiratory compromise is further increased with the utilization of neuromuscular blockade. Consistently, opioid analgesia has proven to be complex in OSA, as patients are particularly prone to opioid-induced respiratory depression. Moreover, basic features of OSA, including intermittent hypoxemia and repetitive sleep fragmentation, gradually precipitate a higher sensitivity to opioid analgesic potency along with an increased perception of pain. Hence, regional anesthesia by blockade of neural pathways directly at the site of surgical trauma as well as multimodal analgesia by facilitating additive and synergistic analgesic effects are both strongly supported in the literature as interventions that may reduce perioperative complication risk. Health care institutions are increasingly allocating resources, including those of postoperative enhanced monitoring, in an effort to increase patient safety. The implementation of evidence-based perioperative management strategies is however burdened by the rising prevalence of OSA, the large heterogeneity in disease severity, and the lack of evidence on the efficacy of costly perioperative measures. Screening and monitoring algorithms, as well as reliable risk predictors, are urgently needed to identify OSA patients that are truly in need of extended postoperative surveillance and care. The perioperative community is therefore challenged to develop feasible pathways and measures that can confer increased patient safety and prevent complications in patients with OSA.
引用
- Cozowicz C, Memtsoudis SG. Perioperative Management of the Patient With Obstructive Sleep Apnea: A Narrative Review. Anesth Analg. 2021. PMID: 33857965. doi:10.1213/ANE.0000000000005444
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。